Thus, the current results that demonstrate an increased cytotoxic effect of TRAIL and NDV in both glioma cells and GSCs may provide a mechanism to bypass the relative resistance of GSCs to both TRAIL and NDV. This evidence concerns the gene TNFSF10 and central nervous system cancer.